98%
921
2 minutes
20
Eleven patients with symptomatic talus osteochondral defects who underwent subchondroplasty with bone marrow aspirate concentrate injection were retrospectively reviewed. Foot and Ankle Outcome Score and visual analog scale pain score were recorded preoperatively and at the 1-year postoperative visit. The mean osteochondral defect size was 1.3×1.4 cm. The weight-bearing visual analog scale pain score improved from a mean of 7.8 to 1.8, and the Foot and Ankle Outcome Score improved from a mean of 67.1 to 89.6. At 1-year follow-up, 10 patients reported they would have the procedure again. Subchondroplasty and bone marrow aspirate concentrate injection offered good pain relief for talus osteochondral defects. The procedure allows immediate weight bearing postoperatively and does not compromise future treatments. [Orthopedics. 2018; 41(5):e734-e737.].
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3928/01477447-20180724-06 | DOI Listing |
J Knee Surg
May 2025
Zimmer Biomet, Inc. Warsaw, Indiana.
Bone marrow lesions (BMLs) have a strong correlation to patient-reported pain, functional limitations, joint deterioration, and rapid progression to total knee arthroplasty. The Subchondroplasty (SCP) procedure uses AccuFill, a calcium phosphate bone substitute material (BSM), to treat bone defects such as microtrabecular fractures and BML. This observational, prospective, multicenter, cohort study evaluated the effect of the SCP procedure at the 2-year follow-up for 70 patients with knee BML.
View Article and Find Full Text PDFRadiol Case Rep
February 2025
Department of Radiology, University of Michigan, Ann Arbor, MI, USA.
Osteoid Osteoma (OO) is a common primary bone tumor that often presents with night pain in younger orthopedic patients. Although typically extra-articular, intra-articular presentations may be difficult to diagnose. While magnetic resonance imaging (MRI) provides excellent detailed imaging of the articular surface, it has been reported to lead to occasional misdiagnosis given limitations in spatial resolution, particularly for smaller lesions.
View Article and Find Full Text PDFCartilage
June 2025
IRCCS Humanitas Research Hospital, Rozzano, Italy.
Bone marrow lesions (BMLs) are MRI-visible subchondral bone alterations, highly correlated with symptoms in the knee. Subchondroplasty (SCP) is able to fill the subchondral defects associated with BMLs using an injectable bone substitute material. The aim of the present study is to evaluate the 12-month outcomes of the SCP in the treatment of symptoms of mild-to-moderate knee osteoarthritis (OA) patients with persistent BMLs of the knee.
View Article and Find Full Text PDFJ Long Term Eff Med Implants
June 2024
First Department of Orthopedics, National and Kapodistrian University of Athens, Medical School, ATTIKON University General Hospital, GREECE.
An alternative approach to the major problem of osteoarthritis that has begun to pique the interest of researchers focuses on the pathology of the subchondral bone, its constant cross-talk with the articular cartilage, and its interaction with the joint. The presence of bone marrow lesions, detectable on MRI scans, has proven to be a cause of pain as well as a predictor of the progression of degenerative changes. Subchondroplasty is a relatively new surgical procedure for the treatment of these lesions, in which injectable calcium phosphate bone cement is infused into the affected area percutaneously, under fluoroscopic guidance.
View Article and Find Full Text PDF